This patent is based on the novel idea that non-inflammatory and safe components comprising select 1-2 vitamins and a flavonoid in a phamaceutically acceptable carrier work synergistically to significantly enhance immune responses against co-administered antigens derived from infectious agents, including neglected diseases.